Expand UTHR Menu
UTHR MENU

UTHR Latest Press Releases

-- March 11, 2026 --

United Therapeutics Corporation Announces Full Results of TETON-2 Phase 3 Clinical Trial Published in The New England Journal of Medicine Business Wire 6:14 PM

-- March 9, 2026 --

United Therapeutics Corporation Announces $2 Billion Stock Repurchase Authorization and Enters into $1.5 Billion Accelerated Share Repurchase Program Business Wire 7:00 AM

-- March 3, 2026 --

United Therapeutics Corporation to Present at the Leerink Global Healthcare Conference Business Wire 7:00 AM

-- March 2, 2026 --

United Therapeutics Corporation Announces Ralinepag Achieved 55% Reduction in Risk of Clinical Worsening in Pivotal Pulmonary Arterial Hypertension Study, Delivering Exceptional, Highly Statistically Significant Efficacy Business Wire 6:30 AM

-- February 25, 2026 --

United Therapeutics Corporation Reports Fourth Quarter and Full Year 2025 Financial Results Business Wire 6:30 AM

-- February 23, 2026 --

United Therapeutics Corporation to Present at the TD Cowen 46th Annual Health Care Conference Business Wire 7:00 AM

-- February 11, 2026 --

United Therapeutics Corporation to Report Fourth Quarter and Full Year 2025 Financial Results Before the Market Opens on Wednesday, February 25, 2026 Business Wire 7:00 AM

-- January 26, 2026 --

United Therapeutics Announces Positive Results from Phase 1 Study of miroliverELAP in Patients with Acute Liver Failure Business Wire 7:00 AM

-- January 22, 2026 --

United Therapeutics Corporation Announces Appointment of Kevin J. Tracey to its Board of Directors Business Wire 7:00 AM

-- January 7, 2026 --

ReAlta Life Sciences Announces Appointment of Jonathan Rigby to Board of Directors Business Wire 8:00 AM

-- January 5, 2026 --

United Therapeutics Corporation to Present at the 44th Annual J.P. Morgan Healthcare Conference Business Wire 7:00 AM

-- November 4, 2025 --

United Therapeutics Corporation to Present at Upcoming Investor Conferences Business Wire 7:00 AM

-- November 3, 2025 --

United Therapeutics Corporation Announces First Transplant in EXPAND Clinical Trial of UKidney in Patients With End-Stage Renal Disease Business Wire 7:00 AM

-- October 29, 2025 --

United Therapeutics Corporation Reports Record Third Quarter 2025 Financial Results Business Wire 6:30 AM
Market Data Delayed 15 Minutes